Grants and Contributions:
Title:
Pancreas ex-vivo support
Agreement Number:
1023909
Agreement Value:
$300,000.00
Agreement Date:
Oct 1, 2024 - Jun 29, 2025
Description:
Traferox will design, manufacture, and validate a system to perform normothermic ex vivo perfusion of the pancreas. In normothermic ex vivo pancreas perfusion, the excised pancreas is perfused with a solution containing red blood cells and maintained at body temperature for several hours in preparation for transplantation. Normothermic ex vivo pancreas perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant, as well as functional improvement. This project will create a system suitable for preclinical and clinical research.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mississauga, Ontario, CA L5L 5Y7
Reference Number:
172-2024-2025-Q3-1023909
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
717995286
Recipient Type:
For-profit organization
Recipient's Legal Name:
Traferox Technologies Inc
Federal Riding Name:
Mississauga--Erin Mills
Federal Riding Number:
35060
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110